© Siemens

Siemens Healthineers recorded an increase in order intake: it rose from €4.125 billion in Q1/20 to €4.387 billion in the first quarter of 2021. This also includes a new volume from coronavirus antigen rapid tests. However, volume growth is being held back by strong negative currency translation effects. Sales revenue increased by 13% from EUR 3.587 billion in the same period of the previous year to EUR 3.868 billion in the first quarter. Adjusted EBITA rose from a low comparative basis, but included negative effects of EUR 67 million in connection with the planned acquisition of Varian Medical Systems as well as negative currency translation effects.